Ioannis Stefanidis

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

Medicine, Endocrinology, Nephrology +10

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Imaging Modalities for Renal Artery Stenosis in Suspected Renovascular Hypertension: Prospective Intraindividual Comparison of Color Doppler US, CT Angiography, GD-Enhanced MR Angiography, and Digital Substraction Angiography

Christos Rountas, Marianna Vlychou, Katerina Vassiou et al. · Renal Failure · 2007 · 186 citations · Full text

Medicine, Nephrology, Radiology +16

Effect of exercise training and dopamine agonists in patients with uremic restless legs syndrome: a six-month randomized, partially double-blind, placebo-controlled comparative study

Christoforos D. Giannaki, Giorgos K. Sakkas, Christina Karatzaferi et al. · BMC Nephrology · 2013 · 144 citations · Full text

Medicine, Nephrology, Pharmacology +16

A single-blind randomized controlled trial to evaluate the effect of 6 months of progressive aerobic exercise training in patients with uraemic restless legs syndrome

Christoforos D. Giannaki, Georgios M. Hadjigeorgiou, Christina Karatzaferi et al. · Nephrology Dialysis Transplantation · 2013 · 126 citations

Medicine, Physiology, Rehabilitation Medicine +14